Coronavirus Disease 2019 (COVID-19)
Updated: Apr 06, 2023 Overview Practice Essentials Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel...
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Nirmatrelvir is an orally bioavailable protease inhibitor that is active against MPRO, a viral protease that plays an essential role in...
Remdesivir
Remdesivir is a nucleotide prodrug of an adenosine analog. It binds to the viral RNA-dependent RNA polymerase and inhibits viral...
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Nirmatrelvir is an orally bioavailable protease inhibitor that is active against MPRO, a viral protease that plays an essential role in...
Myocarditis
Summary Myocarditis is an inflammatory disease of the myocardium with a wide range of clinical presentations, from subtle to devastating....
Coronavirus Disease 2019 (COVID-19)
Practice Essentials Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus called severe acute...
Drug Treatment for COVID-19: A Quick Summary for PCPs
Information about COVID has evolved so quickly that it can be difficult for clinicians to feel confident that they are staying current....
The Great Invader: How COVID-19 AttacksEvery Organ
We have underestimated and misunderstood COVID-19 since it first appeared. And as we learn more, it's clear that COVID-19 can be more...
Acute Respiratory Distress Syndrome (ARDS)
ADRS in one of the causes of death not also in the Covid19 H phase but also in a lot of systemic diseases. This is a review to sumarize it.
COPD Patients Face Much Higher Risk of Severe COVID-19
NEW YORK (Reuters Health) - Patients with chronic obstructive pulmonary disease (COPD) have more than four times higher odds of...
